Five-Year Extended Hormone Therapy No Better in Breast Cancer
Findings compared with two years of extended adjuvant anastrozole in postmenopausal women with hormone-receptor-positive breast cancer
Most With Reaction to mRNA COVID-19 Vaccine Tolerate Second Dose
Most patients with immediate, potentially allergic reaction to Pfizer-BioNTech or Moderna mRNA COVID-19 vaccine tolerate second dose
FDA Approves First Biosimilar Insulin Product
Semglee (insulin glargine-yfgn) is biosimilar to and interchangeable with Lantus (insulin glargine), provides cost-effective option
CDC Now Says Vaccinated Should Be Tested After COVID-19 Exposure, Even Without Symptoms
Even though fully vaccinated people may still get infected, infections tend to have mild or no symptoms
Black Women’s Group Sues Johnson & Johnson Over Baby Powder
Lawsuit claims that J&J targeted baby powder ads to Black women despite knowing it contained ingredients that could cause ovarian cancer
Vaccinated Americans Can Soon Visit the U.K. Without Quarantining
U.S. officials have not yet decided to stop restricting the entry of British travelers and others into the United States
Biden Weighs ‘Vaccine or Testing’ Mandate for Federal Employees
White House officials said Tuesday they would reveal more about the president's plans later this week
Third COVID-19 Vaccine Dose May Prompt Response in Transplant Recipients
Third dose of mRNA-1273 vaccine induces serologic response in 49 percent of kidney recipients who did not respond after two doses
Shorter Course of Antibiotics Noninferior for UTI in Afebrile Men
Seven days of antibiotics noninferior to 14-day course for resolution of symptoms among afebrile men with urinary tract infection
Pfizer Says Third Shot of Vaccine Boosts COVID-19 Protection
Company has said it plans to seek U.S. approval for a third booster shot of its vaccine, but the issue has been controversial
